Trial Profile
Efficacy and safety observation of recombination Benaglutide and sitagliptin vs. Benaglutide monotherapy in type 2 diabetic patients with unsatisfied glycemia control under metformin treatment
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Benaglutide (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Jul 2018 New trial record